RecruitingNCT07250958
Dome-Only Aneurysm Coiling in Severe Aneurysmal Subarachnoid Hemorrhage
Dome-Only Aneurysm Coiling in Severe Aneurysmal Subarachnoid Hemorrhage Observational Study
Sponsor
University of Louisville
Enrollment
30 participants
Start Date
Mar 12, 2026
Study Type
OBSERVATIONAL
Conditions
Summary
The DOME study is a clinical trial exploring a new treatment approach for patients who suffered a severe brain bleed due to an aneurysm.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with aneurysmal subarachnoid hemorrhage. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07250958
Related Trials
Nitric Oxide Consumption as a Predictor of Vasospasm in Subarachnoid Hemorrhage
NCT076149062 locations
Multi-Center Registry Cohort Study on Prognostic Factors and Prediction Model Construction in Aneurysmal SAH
NCT057380831 location
Early Lumbar Drainage Plus Intrathecal Urokinase in Severe Aneurysmal Subarachnoid Hemorrhage (LD-ITUK)
NCT0628464225 locations
Tocilizumab-aazg for Hemorrhage: Reduction of Ischemic Vascular Events
NCT068634801 location
Microvention AnEurysm & STroke Real-life Data cOllection
NCT064944361 location